Literature DB >> 32005532

Meta-analysis of randomized controlled trials of the effects of probiotics on functional constipation in adults.

Chengcheng Zhang1, Jinchi Jiang1, Fengwei Tian1, Jianxin Zhao1, Hao Zhang2, Qixiao Zhai3, Wei Chen4.   

Abstract

BACKGROUND & AIMS: Clinical trials have reported controversial results regarding the effectiveness of probiotics in alleviating functional constipation in adults. We reviewed relevant randomized controlled trials to elucidate the effectiveness of probiotics on constipation symptoms in adults with functional constipation.
METHODS: We searched Medline, the Cochrane Library, Web of Science, and Google Scholar for relevant articles published up to April 2019. The primary outcomes of interest were stool frequency, gut transit time (GTT), stool consistency, and bloating. Two authors independently performed the study selection, risk-of-bias assessment, and data extraction. The outcome data were extracted from each included study and synthesized using weighted mean differences (WMDs) or standardized mean differences (SMDs). Pooled data synthesis was performed using a random-effects model.
RESULTS: In total, 2327 relevant studies were identified, 15 of which were found to be eligible randomized controlled trials and were included in the meta-analysis. Pooling of the extracted data demonstrated that probiotic consumption significantly reduced the whole GTT by 13.75 h [95% confidence interval (CI): -21.93 to -5.56 h] and increased the stool frequency by 0.98 (95% CI: 0.36 to 1.60) bowel movements per week. This increase was significant with the consumption of multispecies probiotics [at least two bacteria; WMD: 1.22 (95% CI: 0.50 to 1.94) bowel movements per week] but not with the consumption of Bifidobacterium lactis [WMD: 1.34 (95% CI: -0.27 to 2.94) bowel movements per week] or B. longum [WMD: -0.02 (95% CI: -0.56 to 0.53) bowel movements per week] alone. Multispecies probiotics (WMD: 1.37; 95% CI: 0.72 to 2.01), but not single-species probiotics (WMD: 1.18; 95% CI: -0.59 to 2.96), improved stool consistency (WMD: 1.30; 95% CI: 0.22 to 2.38). Similarly, multispecies probiotics (at least two bacteria; WMD: -0.49; 95% CI: -0.85 to -0.13), but not single-species probiotics (WMD: -0.24; 95% CI: -0.55 to 0.07), significantly decreased bloating. Performance bias were high, whereas detection bias was unclear because of inadequate reporting.
CONCLUSION: Consumption of probiotics, in particular, multispecies probiotics, may substantially reduce the GTT, increase the stool frequency, and improve the stool consistency. Thus, probiotics can be regarded as safe and natural agents for alleviation of functional constipation in adults.
Copyright © 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Adult; Clinical randomized trial; Constipation; Probiotic; meta-analysis

Year:  2020        PMID: 32005532     DOI: 10.1016/j.clnu.2020.01.005

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  10 in total

Review 1.  The Gut Microbiome and Colonic Motility Disorders: A Practical Framework for the Gastroenterologist.

Authors:  Wenjie Ma; David A Drew; Kyle Staller
Journal:  Curr Gastroenterol Rep       Date:  2022-08-09

2.  Symptoms Originally Attributed to Thyroid Dysfunction Were Instead Caused by Suboptimal Gastrointestinal Health: A Case Series and Literature Review.

Authors:  Michael Ruscio; Gavin Guard; Joe Mather
Journal:  Integr Med (Encinitas)       Date:  2022-07

3.  PHAGE-2 Study: Supplemental Bacteriophages Extend Bifidobacterium animalis subsp. lactis BL04 Benefits on Gut Health and Microbiota in Healthy Adults.

Authors:  Diana S Grubb; Scott D Wrigley; Kimberley E Freedman; Yuren Wei; Allegra R Vazquez; Roxanne E Trotter; Taylor C Wallace; Sarah A Johnson; Tiffany L Weir
Journal:  Nutrients       Date:  2020-08-17       Impact factor: 5.717

4.  Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson's disease: A randomised controlled trial.

Authors:  Azliza Ibrahim; Raja Affendi Raja Ali; Mohd Rizal Abdul Manaf; Norfazilah Ahmad; Farah Waheeda Tajurruddin; Wong Zhi Qin; Siti Hajar Md Desa; Norlinah Mohamed Ibrahim
Journal:  PLoS One       Date:  2020-12-31       Impact factor: 3.240

5.  Efficacy of Probiotic Compounds in Relieving Constipation and Their Colonization in Gut Microbiota.

Authors:  Yuan He; Leilei Zhu; Jialun Chen; Xin Tang; Mingluo Pan; Weiwei Yuan; Hongchao Wang
Journal:  Molecules       Date:  2022-01-20       Impact factor: 4.411

6.  Effects of Lactobacillus plantarum P9 Probiotics on Defecation and Quality of Life of Individuals with Chronic Constipation: Protocol for a Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Authors:  Wenjun Liu; Nong-Hua Lu; Xu Zhou; Yingmeng Li; Yong Xie; Longjin Zheng; Weifeng Zhu; Qiuping Xiao; Ni Yang; Kexuan Zuo; Qingni Wu; Tielong Xu; Heping Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-13       Impact factor: 2.650

Review 7.  Bacillus clausii for Gastrointestinal Disorders: A Narrative Literature Review.

Authors:  Carlos Patricio Acosta-Rodríguez-Bueno; Ana Teresa Abreu Y Abreu; Francisco Guarner; Mary Jean V Guno; Ender Pehlivanoğlu; Marcos Perez
Journal:  Adv Ther       Date:  2022-08-26       Impact factor: 4.070

8.  The effect of probiotics used as a single therapy on functional constipation: Study protocol for a systematic review and meta-analysis.

Authors:  Yong Wen; Jun Li; Xuegui Tang
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.889

9.  Microbiota profile and efficacy of probiotic supplementation on laxation in adults affected by Prader-Willi Syndrome: A randomized, double-blind, crossover trial.

Authors:  Zainab Alyousif; Jennifer L Miller; Jeremie Auger; Mariana Sandoval; Amanda Piano; Thomas A Tompkins; Wendy J Dahl
Journal:  Mol Genet Genomic Med       Date:  2020-10-25       Impact factor: 2.183

10.  Alterations in Gut Microbiome Composition and Function in Irritable Bowel Syndrome and Increased Probiotic Abundance with Daily Supplementation.

Authors:  Joann Phan; Divya Nair; Suneer Jain; Thibaut Montagne; Demi Valeria Flores; Andre Nguyen; Summer Dietsche; Saurabh Gombar; Philip Cotter
Journal:  mSystems       Date:  2021-11-02       Impact factor: 6.496

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.